Celyad Oncology

Euronext

Celyad Oncology sells 28.8% shares to Fortress Group for $32.5mn
ByChenos Kahn December 3, 2021December 3, 2021

BRUSSELS, BELGIUM: Celyad Oncology SA has entered into a subscription agreement with an affiliate of Fortress Investment Group for the private placement of 6.5 million ordinary shares for gross proceeds of USD 32.5 million (about EUR 28.7 million). The subscription…

Read More Celyad Oncology sells 28.8% shares to Fortress Group for $32.5mn
Euronext

Celyad Oncology signs $40 million equity purchase agreement with Lincoln Park Capital
ByNNR January 7, 2021January 19, 2021

BRUSSELS: Celyad Oncology SA has entered into a committed equity purchase agreement for up to $40 million with Lincoln Park Capital Fund LLC, a Chicago-based institutional investor. Over the 24-month term of the Purchase Agreement, the Company will have the…

Read More Celyad Oncology signs $40 million equity purchase agreement with Lincoln Park Capital

Exit mobile version